BlueRock Therapeutics Angeforderte Firma
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Weiterlesen
Good, exciting science combined with questionable, arrogant management.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
There is a collegial and (mostly) respectful atmosphere.
Warum fühlen Sie sich unterbewertet und was würde Sie bei Ihrer Vergütung besser fühlen lassen?
The LTI incentives are weak compared to other small biotechs and even larger biotechs/pharma.
Other Employee Reviews for BlueRock Therapeutics
×